IN2014MN00880A - - Google Patents

Info

Publication number
IN2014MN00880A
IN2014MN00880A IN880MUN2014A IN2014MN00880A IN 2014MN00880 A IN2014MN00880 A IN 2014MN00880A IN 880MUN2014 A IN880MUN2014 A IN 880MUN2014A IN 2014MN00880 A IN2014MN00880 A IN 2014MN00880A
Authority
IN
India
Prior art keywords
composition
degrees celsius
buffer
viscosity
mpas
Prior art date
Application number
Other languages
English (en)
Inventor
Evan C Unger
Jennifer L Johnson
Original Assignee
Nuvox Pharma L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvox Pharma L L C filed Critical Nuvox Pharma L L C
Publication of IN2014MN00880A publication Critical patent/IN2014MN00880A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • A61K31/025Halogenated hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • A61K31/025Halogenated hydrocarbons carbocyclic
    • A61K31/03Halogenated hydrocarbons carbocyclic aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN880MUN2014 2011-10-13 2012-10-15 IN2014MN00880A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/273,115 US8822549B2 (en) 2011-10-13 2011-10-13 Buffered oxygen therapeutic
PCT/US2012/060284 WO2013056246A1 (en) 2011-10-13 2012-10-15 Buffered oxygen therapeutic

Publications (1)

Publication Number Publication Date
IN2014MN00880A true IN2014MN00880A (ru) 2015-04-17

Family

ID=48082584

Family Applications (1)

Application Number Title Priority Date Filing Date
IN880MUN2014 IN2014MN00880A (ru) 2011-10-13 2012-10-15

Country Status (8)

Country Link
US (1) US8822549B2 (ru)
EP (1) EP2766001B1 (ru)
JP (3) JP6117220B2 (ru)
CN (2) CN108685882A (ru)
AU (1) AU2012323862B2 (ru)
CA (2) CA2851522C (ru)
IN (1) IN2014MN00880A (ru)
WO (1) WO2013056246A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8822549B2 (en) * 2011-10-13 2014-09-02 Jennifer L. Johnson Buffered oxygen therapeutic
US9700523B2 (en) * 2011-10-13 2017-07-11 Nuvox Pharma Llc Buffered oxygen therapeutic
WO2015034940A1 (en) * 2013-09-03 2015-03-12 Arizona Board Of Regents On Behalf Of The University Of Arizona Cardioprotectant to reduce damage from heart attack
CN113398070A (zh) * 2014-03-05 2021-09-17 埃文·C·昂格尔 利用氧气疗法的分割放疗和化疗
BR112018012618A2 (pt) * 2015-12-21 2018-12-04 C Unger Evan composições da nano emulsão de fluorocarbonos e métodos de preparação e uso dos mesmos
CN115814325B (zh) * 2022-11-23 2024-04-19 浙江工业大学 一种含氟灭火剂组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423077A (en) * 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5656211A (en) * 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5114932A (en) * 1990-11-30 1992-05-19 Runge Thomas M Hyperosmolar oxyreplete hemosubstitute
US5196199A (en) * 1990-12-14 1993-03-23 Fuisz Technologies Ltd. Hydrophilic form of perfluoro compounds and method of manufacture
US5628930A (en) 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5595687A (en) 1992-10-30 1997-01-21 Thomas Jefferson University Emulsion stability
NZ262237A (en) 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US20030032879A1 (en) 1997-07-07 2003-02-13 Steven Quay Microbubble formation using ultrasound
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
CN102395548A (zh) 2009-04-15 2012-03-28 奥斯金生医公司 全氟化碳类乳液
US8822549B2 (en) * 2011-10-13 2014-09-02 Jennifer L. Johnson Buffered oxygen therapeutic

Also Published As

Publication number Publication date
CN104039317A (zh) 2014-09-10
CA3057480C (en) 2021-07-20
JP2014528487A (ja) 2014-10-27
JP6117220B2 (ja) 2017-04-19
JP6479870B2 (ja) 2019-03-06
WO2013056246A1 (en) 2013-04-18
CA2851522C (en) 2019-11-26
EP2766001B1 (en) 2024-05-15
AU2012323862A1 (en) 2014-05-29
AU2012323862B2 (en) 2015-07-09
JP2017132789A (ja) 2017-08-03
EP2766001A4 (en) 2015-06-10
CN104039317B (zh) 2018-05-25
CA3057480A1 (en) 2013-04-18
JP6789328B2 (ja) 2020-11-25
CN108685882A (zh) 2018-10-23
JP2019089816A (ja) 2019-06-13
CA2851522A1 (en) 2013-04-18
US8822549B2 (en) 2014-09-02
US20130096204A1 (en) 2013-04-18
EP2766001A1 (en) 2014-08-20

Similar Documents

Publication Publication Date Title
CY1120646T1 (el) Προγονικα κυτταρα μεσοδερμικης προελευσης
HK1218648A1 (zh) 甲基修飾酶的調節劑、其組合物及用途
IN2014MN00880A (ru)
MX366435B (es) Papel tisu suave y voluminoso.
MX2013004495A (es) Microorganismo que produce o-fosfoserina y metodo para producir l-cisteina o derivados de la misma a partir de o-fosfoserina usando los mismos.
MY178142A (en) Anti-phf-tau antibodies and their uses
MY186864A (en) Fusion immunomodulatory proteins and methods for making same
MX339059B (es) Composiciones para el cuidado personal.
MX349630B (es) Alfa-amilasas.
MX355295B (es) Artículos para el cuidado personal.
MX347165B (es) Composicion efervescente en forma solida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales.
IN2014DN10712A (ru)
IN2014DN08721A (ru)
MX358096B (es) Composiciones azeotropicas y similares a azeotropo de eteres de metil perfluorohepteno y trans-1, 2-dicloroetileno y usos de estas.
EP3039137A4 (en) Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
IN2014DN10710A (ru)
MX2019003619A (es) Formulaciones de bromocriptina.
MX354368B (es) Paño con solucion de polimero en gel para el cuidado personal y la limpieza del hogar.
IN2014DN06104A (ru)
MX356178B (es) Uso de azucares en matriz de estabilizacion y composiciones solidas.
AU2016335217A8 (en) Antigen receptors and uses thereof
MY165500A (en) Use of methylhydroxyethyl cellulose as cement additive
MX2014005854A (es) Procedimiento de produccion de un cojinete deslizante que comprende un compuesto de cuni2si, cufe2p o cusnx.
MY166879A (en) Attenuated swine influenza vaccines and methods of making and use thereof
WO2015027160A3 (en) Allosteric modulators of the cannibinoid 1 receptor